Skip to main content
IDWeek 2021 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
View Session ViewAttendees 36

Adult ID

HIV-STD-TB

Trainee
Meet-the-Professor

50 - Most Challenging Cases: Difficult ART Management Cases

Thursday, September 30, 2021
5:15 PM - 6:30 PM EDT

    Moderator(s)

  • Harry Lampiris, MD

    Professor
    University of California, San Francisco
    San Francisco, CA, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

    • Speaker(s)

  • Colleen Kelley, MD, MPH

    Associate Professor of Medicine
    Emory University
    Decatur, GA, United States

    Gilead Sciences (Individual(s) Involved: Self): Grant/Research Support; Moderna (Individual(s) Involved: Self): Grant/Research Support; Novavax (Individual(s) Involved: Self): Grant/Research Support; Viiv (Individual(s) Involved: Self): Grant/Research Support

  • Susa Coffey, MD

    Professor of Medicine
    University of California San Francisco
    San Franciaco, CA, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

Participants should be aware of the following financial/non-financial relationships:
Harry W. Lampiris, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Colleen F. Kelley, MD, MPH: Gilead Sciences (Individual(s) Involved: Self): Grant/Research Support; Moderna (Individual(s) Involved: Self): Grant/Research Support; Novavax (Individual(s) Involved: Self): Grant/Research Support; Viiv (Individual(s) Involved: Self): Grant/Research Support
Susa Coffey, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
ACPE Credits: ACPE 1.25 Knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-0000-21-001-H01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:
  • describe approaches to management of ARV Treatment Failure
  • dIscuss novel approaches to ART treatment simplification
  • treat multidrug-resistant HIV infections in a case-based approach

Presentations:

  • Most Challenging Cases: Difficult ART Management Cases - Speaker 1

    Speaker: Colleen F. Kelley, MD, MPH – Emory University

  • Most Challenging Cases: Difficult ART Management Cases - Speaker 2

    Speaker: Susa Coffey, MD – University of California San Francisco